NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d‐2‐hydroxyglutaric aciduria
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The inherited neurometabolic disease d‐2‐hydroxyglutaric aciduria is complicated by progressive neurodegeneration of vulnerable brain regions during infancy and early childhood, frequently presenting with hypotonia, epilepsy and psychomotor retardation. Here, we report that the pathogenetic role of the endogenously accumulating metabolite d‐2‐hydroxyglutarate (D‐2), which is structurally similar to the excitatory amino acid glutamate, is mediated by at least three mechanisms. (i) D‐2‐induced excitotoxic cell damage in primary neuronal cultures from chick and rat involved N‐methyl‐d‐aspartate (NMDA) receptor activation. Indeed, D‐2 activated recombinant NMDA receptors (NR1/NR2A, NR1/NR2B) but not recombinant alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole (AMPA) receptors in HEK293 cells. (ii) Fluorescence microscopy using fura‐2 as a calcium indicator and the oxidant‐sensitive dye dihydrorhodamine‐123 revealed that D‐2 disturbed intracellular calcium homeostasis and elicited the generation of reactive oxygen species. (iii) D‐2 reduced complex V (ATP synthase) activity of the mitochondrial respiratory chain, reflecting an impaired energy metabolism due to inhibition of ATP synthesis but without affecting the electron‐transferring complexes I–IV. Thus, D‐2 stimulates neurodegeneration by mechanisms well‐known for glutamate, NMDA or mitochondrial toxins. In conclusion, excitotoxicity contributes to the neuropathology of d‐2‐hydroxyglutaric aciduria, highlighting new neuroprotective strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism
MITCHELL, P. (1961) · Nature · doi:10.1038/191144a0 · Cited by 4,704
MacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J., & Barker, J. L. (1986) · Nature · doi:10.1038/321519a0 · Cited by 1,835
Back, S. A., Gan, X., Li, Y., Rosenberg, P. A., & Volpe, J. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06241.1998 · Cited by 586 · cited 1×
“Because immature oligodendroglial cells are highly vulnerable to oxidative stress (Back et al., 1998), it can be speculated that D-2-induced ROS generation may contribute to white matter disease in D-2-hydroxyglutaric aciduria.”
BackgroundD‐2‐hydroxyglutaric aciduria: Case report and biochemical studies
Chalmers, R. A., Lawson, A. M., Watts, R. W. E., Tavill, A. S., Kamerling, J. P., Hey, E., & Ogilvie, D. (1980) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02312516 · Cited by 135 · cited 1×
“D-2-Hydroxyglutaric aciduria, ®rst described in 1980 by Chalmers et al (1980), is an inborn error of metabolism belonging to a distinct subgroup of organic acid disorders (OADs) termed cerebral OADs due to predominantly neurological presentation (Hoffmann et al., 1994).”
Cited by
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
“The ability of 2HG to act as an NMDA receptor agonist may contribute to this effect 16 .”
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
“2HG as an Oncometabolite Although 2HG has been proposed to increase ROS levels in patients with inborn errors of 2HG metabolism (Kolker et al., 2002b; Latini et al., 2003), to date we have no evidence that the metabolite acts as a mutagen.”
BackgroundIsocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Chan, S. M., Thomas, D., Corces-Zimmerman, M. R., Xavy, S., Rastogi, S., Hong, W.-J., Zhao, F., Medeiros, B. C., Tyvoll, D. A., & Majeti, R. (2015) · Nature Medicine · doi:10.1038/nm.3788 · Cited by 577
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Losman, J.-A., & Kaelin, W. G. (2013) · Genes & Development · doi:10.1101/gad.217406.113 · Cited by 570
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Bunse, L., Pusch, S., Bunse, T., Sahm, F., Sanghvi, K., Friedrich, M., Alansary, D., Sonner, J. K., Green, E., Deumelandt, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0095-6 · Cited by 539
Self-citation
Metadata
- Authors
- Kölker, S., Pawlak, V., Ahlemeyer, B., Okun, J. G., Hörster, F., Mayatepek, E., Krieglstein, J., Hoffmann, G. F., & Köhr, G.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 16
- Issue
- 1
- Pages
- 21-28
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2074534625
- Cited by
- 134
- References
- 4
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d‐2‐hydroxyglutaric aciduria. https://app.cochat.ai/papers/10.1046/j.1460-9568.2002.02055.x
- The paper
- Kölker, S., Pawlak, V., Ahlemeyer, B., Okun, J. G., Hörster, F., Mayatepek, E., Krieglstein, J., Hoffmann, G. F., & Köhr, G. (2002). NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d‐2‐hydroxyglutaric aciduria. European Journal of Neuroscience. https://doi.org/10.1046/j.1460-9568.2002.02055.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.